JP2011524362A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011524362A5 JP2011524362A5 JP2011513674A JP2011513674A JP2011524362A5 JP 2011524362 A5 JP2011524362 A5 JP 2011524362A5 JP 2011513674 A JP2011513674 A JP 2011513674A JP 2011513674 A JP2011513674 A JP 2011513674A JP 2011524362 A5 JP2011524362 A5 JP 2011524362A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- halo
- neurofibromatosis
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000000217 alkyl group Chemical group 0.000 claims 20
- 125000001475 halogen functional group Chemical group 0.000 claims 14
- 208000009905 Neurofibromatoses Diseases 0.000 claims 12
- 125000003545 alkoxy group Chemical group 0.000 claims 12
- 201000004931 neurofibromatosis Diseases 0.000 claims 12
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 150000001875 compounds Chemical class 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 125000004356 hydroxy functional group Chemical group O* 0.000 claims 6
- 208000013355 benign neoplasm of brain Diseases 0.000 claims 5
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 4
- 208000004378 Choroid plexus papilloma Diseases 0.000 claims 3
- 208000009798 Craniopharyngioma Diseases 0.000 claims 3
- 201000002222 hemangioblastoma Diseases 0.000 claims 3
- 206010027191 meningioma Diseases 0.000 claims 3
- 208000007538 neurilemmoma Diseases 0.000 claims 3
- 210000004560 pineal gland Anatomy 0.000 claims 3
- 208000024719 uterine cervix neoplasm Diseases 0.000 claims 3
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 2
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 2
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 2
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- HHZIURLSWUIHRB-UHFFFAOYSA-N nilotinib Chemical compound C1=NC(C)=CN1C1=CC(NC(=O)C=2C=C(NC=3N=C(C=CN=3)C=3C=NC=CC=3)C(C)=CC=2)=CC(C(F)(F)F)=C1 HHZIURLSWUIHRB-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6115608P | 2008-06-13 | 2008-06-13 | |
| US61/061,156 | 2008-06-13 | ||
| PCT/US2009/046971 WO2009152288A1 (en) | 2008-06-13 | 2009-06-11 | Substituted benzimidazoles for neurofibromatosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011524362A JP2011524362A (ja) | 2011-09-01 |
| JP2011524362A5 true JP2011524362A5 (no) | 2012-07-26 |
Family
ID=40956523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011513674A Withdrawn JP2011524362A (ja) | 2008-06-13 | 2009-06-11 | 神経線維腫症用の置換ベンゾイミダゾール |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110092546A1 (no) |
| EP (1) | EP2288354A1 (no) |
| JP (1) | JP2011524362A (no) |
| KR (1) | KR20110025827A (no) |
| CN (1) | CN102065859B (no) |
| AU (1) | AU2009257487B2 (no) |
| BR (1) | BRPI0915106A2 (no) |
| CA (1) | CA2726376A1 (no) |
| MX (1) | MX2010013683A (no) |
| RU (1) | RU2011100106A (no) |
| TW (1) | TW201004621A (no) |
| WO (1) | WO2009152288A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR085091A1 (es) | 2011-01-26 | 2013-09-11 | Kolltan Pharmaceuticals Inc | Anticuerpos anti-kit y sus usos |
| AU2013295848B2 (en) | 2012-07-25 | 2018-05-24 | Celldex Therapeutics, Inc. | Anti-KIT antibodies and uses thereof |
| CN106659782B (zh) * | 2014-05-23 | 2021-11-09 | 塞尔德克斯医疗公司 | 一种用于嗜酸性粒细胞或肥大细胞相关病症治疗的抗体 |
| KR101880015B1 (ko) | 2017-12-08 | 2018-07-19 | 아주대학교산학협력단 | 인터페론 감마를 유효성분으로 함유하는 신경섬유육종 예방 또는 치료용 조성물 |
| AU2020206036A1 (en) | 2019-01-11 | 2021-08-05 | Naegis Pharmaceuticals Inc. | Leukotriene synthesis inhibitors |
| WO2022268158A1 (zh) * | 2021-06-23 | 2022-12-29 | 正大天晴药业集团股份有限公司 | 作为c-Met激酶抑制剂的化合物治疗I型神经纤维瘤病的用途 |
| CA3233383A1 (en) * | 2021-10-08 | 2023-04-13 | Luc OTTEN | Benzimidazole derivatives for use in the treatment or prevention of a histiocytosis or a craniopharyngioma |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04009541A (es) * | 2002-03-29 | 2005-01-25 | Chiron Corp | Benzazoles sustituidos y uso de los mismos como inhibidores de cinasa raf. |
| PE20070335A1 (es) * | 2005-08-30 | 2007-04-21 | Novartis Ag | Benzimidazoles sustituidos y metodos para su preparacion |
| GB0609378D0 (en) * | 2006-05-11 | 2006-06-21 | Novartis Ag | Organic compounds |
| PE20130814A1 (es) * | 2006-08-30 | 2013-08-08 | Novartis Ag | Sales de benzimidazolil piridil eteres y formulaciones que las contienen |
| US20100074897A1 (en) * | 2006-12-01 | 2010-03-25 | University Of Utah Research Foundation | Methods and Compositions related to HIF-1 alpha |
| CA2924436A1 (en) * | 2007-07-30 | 2009-02-05 | Ardea Biosciences, Inc. | Pharmaceutical combinations of n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide as inhibitors of mek and methods of use |
| WO2009114703A2 (en) * | 2008-03-12 | 2009-09-17 | Fox Chase Cancer Center | Combination therapy for the treatment of cancer |
-
2009
- 2009-06-11 KR KR1020117000776A patent/KR20110025827A/ko not_active Application Discontinuation
- 2009-06-11 US US12/997,770 patent/US20110092546A1/en not_active Abandoned
- 2009-06-11 BR BRPI0915106A patent/BRPI0915106A2/pt not_active IP Right Cessation
- 2009-06-11 AU AU2009257487A patent/AU2009257487B2/en not_active Ceased
- 2009-06-11 JP JP2011513674A patent/JP2011524362A/ja not_active Withdrawn
- 2009-06-11 CA CA2726376A patent/CA2726376A1/en not_active Abandoned
- 2009-06-11 WO PCT/US2009/046971 patent/WO2009152288A1/en active Application Filing
- 2009-06-11 EP EP09763578A patent/EP2288354A1/en not_active Ceased
- 2009-06-11 CN CN2009801221827A patent/CN102065859B/zh not_active Expired - Fee Related
- 2009-06-11 MX MX2010013683A patent/MX2010013683A/es not_active Application Discontinuation
- 2009-06-11 RU RU2011100106/15A patent/RU2011100106A/ru not_active Application Discontinuation
- 2009-06-12 TW TW098119822A patent/TW201004621A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011524362A5 (no) | ||
| JP2009501745A5 (no) | ||
| JP6021805B2 (ja) | 腫瘍治療剤 | |
| JP2011502958A5 (no) | ||
| JP2018515555A5 (no) | ||
| JP2004520292A5 (no) | ||
| JP2013523733A5 (no) | ||
| JP2015500326A5 (no) | ||
| JP2017505293A5 (no) | ||
| JP2009514878A5 (no) | ||
| JP2004512328A5 (no) | ||
| JP2014502979A5 (no) | ||
| JP2010516701A5 (no) | ||
| RU2011100106A (ru) | Замещенные бензимидазолы для лечения нейрофиброматоза | |
| JP2017509694A5 (no) | ||
| JP2016508135A5 (no) | ||
| JP2005505583A5 (no) | ||
| JP2020515645A5 (no) | ||
| JP2004525183A5 (no) | ||
| JP2016540811A5 (no) | ||
| RU2012155691A (ru) | Производные сложного аминоэфира алкалоида и их лекарственные композиции | |
| HRP20100265T1 (hr) | Smjesa od pirimidilaminobenzamid spojeva i imatiniba za liječenje ili prevenciju proliferativnih bolesti | |
| JP2009501744A5 (no) | ||
| JP2011500575A5 (no) | ||
| RU2015150614A (ru) | Новые 3, 4-дигидро-2н-изохинолин-1-оны и 2, 3-дигидро-изоиндол-1-оны |